Institution-Grade Tools, Priced for Individual Investors.
Receive trading alerts directly to your inbox. Try Barchart Plus or Barchart Premier for free today.
/AI%20(artificial%20intelligence)/AI%20microchip%20by%20DesignKingBD360%20via%20Shutterstock.jpg)
/Garmin%20Ltd%20GPS%20tracker-by%20Faaz_Khalif%20via%20Shutterstock.jpg){kind=tracking}
/Tesla%20Inc%20logo%20by-%20baileystock%20via%20iStock.jpg)
/Oracle%20Corp_%20logo%20on%20phone-by%20WonderPix%20via%20Shutterstock.jpg)
/Moderna%20Inc%20HQ-by%20hapabapa%20via%20iStock.jpg)
Moderna is the most shorted S&P 500 stock, with 17.8% short float. But its cancer pipeline, flu approval, and international contracts may surprise bears in 2026.
Robinhood Markets is all set to announce its fiscal first-quarter earnings later this month, and analysts project a double-digit profit growth.
When the market gets tough, do investors go shopping? That seems to be what the charts of this ETF are saying. Here's what to know.
/Intel%20Corp_%20logo%20on%20mobile%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Intel is getting a fresh shot at momentum through its tie-up with Elon Musk. Will fundamentals catch up with sentiment?
Nike stock’s post-earnings slump has crashed its RSI into the late teens. Guggenheim analyst explains why it’s reasonable to bet on a near-term technical rebound in NKE shares.
/Alphabet%20(Google)%20Image%20by%20Markus%20Mainka%20via%20Shutterstock.jpg)
Alphabet is set to announce Q3 results on April 23 following a heavy AI infrastructure spending outlook.
Dollar Tree stock sinks as macro headwinds fueled a broader selloff in consumer-oriented names. Here’s why caution is warranted in buying the dip in DLTR shares.
/Humana%20Inc_%20logo%20on%20laptop-by%20monticello%20via%20Shutterstock.jpg)
Humana shares rally as CMS finalized 2027 Medicare Advantage payments rate at 2.48%. Valuation and options pricing warrant owning HUM shares in 2026.
/Super%20Micro%20Computer%20Inc%20HQ%20photo-by%20Tada%20Images%20via%20Shutterstock.jpg)
Wall Street is growing increasingly cautious on Super Micro as regulatory troubles cast a shadow over its AI-driven momentum.
Upcoming earnings appear hopeful with solid growth estimates and 'Strong Buy' analysts' consensus. Should you add NFLX to your list now?
